Denali Therapeutics Inc.
Символ: DNLI
NASDAQ
20.86
USDПазарна цена днес
-19.5339
Съотношение P/E
-0.2092
Коефициент PEG
2.88B
MRK Cap
- 0.00%
Доходност на DIV
Denali Therapeutics Inc. Структура на управлението
Информация за управлението
Име | Заглавие |
---|---|
Mr. Joe Lewcock Ph.D. | Chief Scientific Officer |
Mr. Tyler M. Nielsen | Senior Vice President of Corporate Finance |
Dr. Dana Andersen | Chief Technical and Manufacturing Officer |
Dr. Ryan J. Watts Ph.D. | Co-Founder, President, Chief Executive Officer & Director |
Dr. Carole Ho M.D. | Chief Medical Officer & Head of Development |
Dr. Laura Hansen | Vice President of Investor Relations |
Dr. Marc Tessier-Lavigne Ph.D. | Co-Founder & Independent Director |
Mr. Chris Walsh | General Counsel |
Mr. Mark Rowen | Vice President of Corporate Development |
Dr. Alexander O. Schuth M.D. | Co-Founder, Chief Financial Officer, Chief Operating Officer & Secretary |
Подобни акции
Може да се интересувате и от:FWBI
Топ мениджмънт:
- Mr. Martin Krusi...
- Dr. Jack A. Syage...
- Ms. Amy Chandler...
CMRA
Топ мениджмънт:
- Ms. Janice Marie ...
- Dr. David Soane ...
- Mr. Michael G. Ca...
CYBN.NE
Топ мениджмънт:
- Dr. Alex L. Nivor...
- Mr. Gabriel Fahel
- Sara Brittany Som...
AURX
Топ мениджмънт:
- Dr. David F. Counts
- Mr. Shaun M. Martin
- Mr. Joseph Del G...
ATNM
Топ мениджмънт:
- Dr. David Gould
- Ms. Sunitha Laks...
- Dr. Paul Diamond...
ROIV
Топ мениджмънт:
- Ms. Kelly Graff
- Ms. Marianne L. R...
- Mr. Josh Chen
URT.WA
Топ мениджмънт:
- Mr. Grzegorz Ste...
- Mr. Tomasz Kostuch